BlueOwl

Blue Owl's 15min Chart Shows MACD Death Cross, KDJ Death Cross.

Blue Owl: Oppenheimer maintains Outperform, PT down to $24 from $27.

Blue Owl Capital

Blue Owl

AI Fears Impact Private Credit, Blue Owl Slumps 26% Amid Tech Rout

Blue Owl shares rise 5.89% intraday after announcing 7.8% dividend yield and $307B AUM growth.

GE HealthCare

GE HealthCare: Barclays Raises PT to $87, Maintains Equal-Weight Rating

Catalyst<ul> <li>Most analysts rate OWL Buy, showing broad institutional optimism.</li> <li>Net inflow trends by medium, large, and extra-large orders suggest positive fund flow dynamics.</li> <li>Long Lower Shadow signals on February 3 and February 5 indicate strong bullish momentum.</li></ul>Risk<ul> <li>Market expectations for OWL tend to be pessimistic despite the positive analyst ratings.</li> <li>Technical indicators show the market is in a volatile state with no clear directional bias.</li> <li>Recent fundamental factors show negative YoY growth in both basic and diluted earnings per share.</li></ul>

Key Factors

Blue Owl Capital’s assets under management (AUM) crossed $300 billion in Q4 2025 amid $17 billion in quarterly capital commitments and $56 billion raised for the full year.Blue Owl’s shares surged 6.12% premarket after exceeding Q4 2025 earnings estimates and crossing the $300 billion AUM milestone, with co-CEOs dismissing AI-driven selloff risks.Blue Owl declared a quarterly dividend of $0.225 per share, offering an annualized yield of ~7.8%, alongside record fundraising results and AUM growth to $307 billion in Q4 2025.Shares fell 6.72% intraday as software industry bad debt surged to $46.9 billion, intensifying risks in the AI-driven private credit market.Blue Owl aims for a 58.5% fee-related earnings margin in 2026, expanding its digital infrastructure and alternative credit platforms after a year of $56 billion in capital raised.

Recent Updates

OWL News